Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by JDavenporton Jul 05, 2022 4:30pm
155 Views
Post# 34803199

RE:RE:Cleaning Up (2)

RE:RE:Cleaning Up (2)There, there, fuzzy. There's a good chance things are going to be ok and you can calm down again.

Should you know about FDA inspections of WuXi manufacturing facilities in China that were in the news today? Might it inform us even a little about Protalix's ProCellEx facilities? Should we care? 

Yes? No?

Personally I thought it was a little too obscure to bother posting but then, it does affect two companies, maybe three, that Bioasis is or has been in business with - WuXi, Chiesi and, maybe, Protalix. Does it mean that PRX-102 may soon be approved? And would it help accelerate the Chiesi LSD programs if they've been held back by FDA manufacturing inspection delays?

Bioasis is taking a long time to generate news and Covid had something to do with it. Is all of that something you "ought" to know about, or even be interested in?

Do you have any interest in why yoiu've lost control of yourself and why you ought to have hope? I have no idea, but if I know this stuff, is it right and proper for me to post it?

Or should I call everybody names and ridicule them like you try to do?

jd
<< Previous
Bullboard Posts
Next >>